What’s trending
-
Innovation at BD
The Future and InnovationDiscover how we’re innovating to drive better outcomes for patients at critical moments throughout their livesLearn more
-
NEWS
BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial VirusLearn MoreBD MAX™ Molecular Diagnostic Respiratory Viral Panel CE Marked to IVD Directive FRANKLIN LAKES, N.J., June 30, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading...
-
NEWS
Harris Poll Survey Reveals Clinicians Continue to See COVID-19 Testing as CriticalLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today unveiled findings from a survey conducted by The Harris...
-
News
Patterns of Bacterial ResistanceListen as BD thought leaders Dr. Gupta and Dr. Yu give insights into patterns of rising bacterial resistance at a Health Watch USA Meeting on May 19, 2022Learn more